Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-18-028123

Options or other derivatives

  • Chief Medical Officer acquired 64,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kwon Paul · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-05-03 Grant or award : show line 1 in the form Stock Option +64,000 $8.49 2028-05-02 64,000 252,512 D
Loading xslF345X03/doc4.xml…